BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38069020)

  • 21. HLA-G and HLA-E in patients with juvenile idiopathic arthritis.
    Prigione I; Penco F; Martini A; Gattorno M; Pistoia V; Morandi F
    Rheumatology (Oxford); 2011 May; 50(5):966-72. PubMed ID: 21186170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
    Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
    Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of HLA class I expression in patients with oral squamous cell carcinoma.
    Koike K; Dehari H; Shimizu S; Nishiyama K; Sonoda T; Ogi K; Kobayashi J; Sasaki T; Sasaya T; Tsuchihashi K; Tsukahara T; Hasegawa T; Torigoe T; Hiratsuka H; Miyazaki A
    Cancer Sci; 2020 May; 111(5):1491-1499. PubMed ID: 32167621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.
    Lin A; Zhu CC; Chen HX; Chen BF; Zhang X; Zhang JG; Wang Q; Zhou WJ; Hu W; Yang HH; Xu HH; Yan WH
    J Cell Mol Med; 2010 Sep; 14(9):2318-29. PubMed ID: 19602033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigens HLA-G, sHLA- G and sHLA- class I in reproductive failure.
    Sipak-Szmigiel O; Ronin-Walknowska E; Cybulski C; Plonka T; Lubiński J
    Folia Histochem Cytobiol; 2007; 45 Suppl 1():S137-41. PubMed ID: 18292821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of HLA-G expression in renal cell carcinoma.
    Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
    Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CLIC1 plasma concentration is associated with lymph node metastases in oral squamous cell carcinoma.
    Wojtera BP; Sobecka A; Szewczyk M; Machczyński P; Suchorska WM; Golusiński W
    Adv Clin Exp Med; 2023 Mar; 32(3):341-347. PubMed ID: 36251793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of high circulating sHLA-G in ovarian carcinoma.
    Babay W; Boujelbene N; Ben Yahia H; Bortolotti D; Zemni I; Ouzari HI; Chelbi H; Mezlini A; Rizzo R; Zidi I
    HLA; 2021 Oct; 98(4):357-365. PubMed ID: 34272932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
    Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
    Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients.
    Wichmann G; Herchenhahn C; Boehm A; Mozet C; Hofer M; Fischer M; Kolb M; Dietz A
    Oral Oncol; 2017 Jun; 69():115-127. PubMed ID: 28559015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease.
    Borghi A; Fogli E; Stignani M; Melchiorri L; Altieri E; Baricordi O; Rizzo R; Virgili A
    Arch Dermatol Res; 2008 Nov; 300(10):551-9. PubMed ID: 18797896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum sHLA-G: Significant diagnostic biomarker with respect to therapy and immunosuppressive mediators in Head and Neck Squamous Cell Carcinoma.
    Agnihotri V; Gupta A; Kumar L; Dey S
    Sci Rep; 2020 Mar; 10(1):3806. PubMed ID: 32123232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative analysis of the sHLA-G protein in seminal plasma.
    Schallmoser A; Raab M; Karn T; Königsberger S; Schmidt E; Breitenbach-Koller H; Sänger N
    Am J Reprod Immunol; 2019 Sep; 82(3):e13152. PubMed ID: 31132194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.
    Schütt P; Schütt B; Switala M; Bauer S; Stamatis G; Opalka B; Eberhardt W; Schuler M; Horn PA; Rebmann V
    Hum Immunol; 2010 May; 71(5):489-95. PubMed ID: 20156510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble human leukocyte antigen-g and its insertion/deletion polymorphism in papillary thyroid carcinoma: novel potential biomarkers of disease?
    Dardano A; Rizzo R; Polini A; Stignani M; Tognini S; Pasqualetti G; Ursino S; Colato C; Ferdeghini M; Baricordi OR; Monzani F
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4080-6. PubMed ID: 22930786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COL11A1 as a potential prognostic target for oral squamous cell carcinoma.
    Di YB; Bao Y; Guo J; Liu W; Zhang SX; Zhang GH; Li TK
    Medicine (Baltimore); 2022 Oct; 101(40):e30989. PubMed ID: 36221427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.
    Fainardi E; Rizzo R; Melchiorri L; Vaghi L; Castellazzi M; Marzola A; Govoni V; Paolino E; Tola MR; Granieri E; Baricordi OR
    J Neuroimmunol; 2003 Sep; 142(1-2):149-58. PubMed ID: 14512174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.